Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income $ 178,101 $ 104,897
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 14,422 19,735
Asset impairment charges 358 0
Non-cash stock-based compensation expense 11,478 12,248
Excess tax benefit from equity awards 0 (10,159)
Net gain on sales of marketable securities and other investments (204) (1,233)
Changes in assets and liabilities:    
Decrease (increase) in accounts receivable, net (38,241) 124,925
Decrease (increase) in inventories 1,187 (31,243)
Decrease in other assets 19,477 34,381
Increase (decrease) in accounts payable (1,547) 4,158
Increase (decrease) in deferred system profit 11,089 (14,504)
Decrease in other liabilities (26,343) (49,423)
Net cash provided by operating activities 169,777 193,782
Cash flows from investing activities:    
Acquisition of non-marketable securities (1,470) 0
Capital expenditures, net (9,883) (7,341)
Purchases of available-for-sale securities (457,512) (343,358)
Proceeds from sale of available-for-sale securities 111,106 200,353
Proceeds from maturity of available-for-sale securities 197,100 184,973
Purchases of trading securities (52,465) (18,267)
Proceeds from sale of trading securities 45,301 15,540
Net cash provided by (used in) investing activities (167,823) 31,900
Cash flows from financing activities:    
Repayment of debt (40,000) (40,000)
Tax withholding payments related to vested and released restricted stock units (17,376) (21,526)
Common stock repurchases 0 (142,592)
Payment of dividends to stockholders (89,313) (101,674)
Excess tax benefit from equity awards 0 10,159
Net cash used in financing activities (146,689) (295,633)
Effect of exchange rate changes on cash and cash equivalents 2,572 (4,377)
Net decrease in cash and cash equivalents (142,163) (74,328)
Cash and cash equivalents at beginning of period 1,108,488 838,025
Cash and cash equivalents at end of period 966,325 763,697
Supplemental cash flow disclosures:    
Income taxes paid, net 39,411 7,844
Interest paid 3,243 3,149
Non-cash activities:    
Purchase of land, property and equipment - investing activities 1,974 1,490
Unsettled common stock repurchase - financing activities 0 9,610
Dividends payable - financing activities $ 12,045 $ 20,892